Smartphone app for heart attack patients- A Clinical Trial
Not yet recruiting
- Conditions
- Chronic ischemic heart disease, unspecified,
- Registration Number
- CTRI/2021/12/038617
- Lead Sponsor
- JIPMER Alumni Association of North America
- Brief Summary
This is a Digital health intervention randomized controlled trial analyzing an Android smartphone application for achieving risk factor modification and medication adherence in stable coronary artery disease patients for six months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 178
Inclusion Criteria
- Patients with clinically documented stable CAD attending cardiology OPD of JIPMER hospital.
- 18 years to 64 years 3.
- Able to use a smart phone with android function 4.
- Able to read English or Tamil.
Exclusion Criteria
- Recent ACS or PCI within 1 month 2.
- Patients awaiting revascularization 3.
- Has visual, auditory, cognitive or motor impairment 4.
- COPD, Peripheral Vascular Disease, Post Pacemaker 6.
- Recent CABG within 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Medication adherence will be measured by assessing the number of adherence failure events (defined as 1 missed dose during a observation cycle of 30 days) using pill counting method and Medication adherence score. Medication adherence will be measured by assessing the number of adherence failure events (defined as 1 missed dose during a observation cycle of 30 days) using pill counting method. | Improvement of CV risk factor targets (defined before). Improvement of CV risk factor targets (defined before). Medication adherence will be measured by assessing the number of adherence failure events (defined as 1 missed dose during a observation cycle of 30 days) using pill counting method. | Improvement of CV risk factor targets (defined before).
- Secondary Outcome Measures
Name Time Method Change in Quality of Life, Stress level and Quality of sleep are the secondary outcomes measured at baseline, 12 weeks and 24 weeks 3
Trial Locations
- Locations (1)
Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER
🇮🇳Pondicherry, PONDICHERRY, India
Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER🇮🇳Pondicherry, PONDICHERRY, IndiaDr Santhosh SatheeshPrincipal investigator9443426244drsanthoshsatheesh@gmail.com